Targeting Herpetic Keratitis by Gene Therapy
Ocular gene therapy is rapidly becoming a reality. By November 2012, approximately 28 clinical trials were approved to assess novel gene therapy agents. Viral infections such as herpetic keratitis caused by herpes simplex virus 1 (HSV-1) can cause serious complications that may lead to blindness. Re...
Saved in:
Main Authors: | Hossein Mostafa Elbadawy, Marine Gailledrat, Carole Desseaux, Diego Ponzin, Stefano Ferrari |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2012/594869 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Herpetic Stromal Keratitis following Selective Laser Trabeculoplasty
by: Nisha Chadha, et al.
Published: (2016-01-01) -
Recurrent Herpetic Stromal Keratitis in Mice: A Model for Studying Human HSK
by: Patrick M. Stuart, et al.
Published: (2012-01-01) -
Recurrence of Herpetic Keratitis after COVID-19 Vaccination: A Report of Two Cases
by: Ali Mahdavi Fard, et al.
Published: (2022-01-01) -
Impaired Fas-Fas Ligand Interactions Result in Greater Recurrent Herpetic Stromal Keratitis in Mice
by: Xiao-Tang Yin, et al.
Published: (2015-01-01) -
Paraneoplastic Limbic Encephalitis Resembling Acute Herpetic Encephalitis
by: Ioannis Markakis, et al.
Published: (2013-01-01)